Annual Report

Overview

The report describes a 6.4 per cent increase in revenue to NOK 565.4 million and highlights the acquisition of dne Pharma's addiction-treatment portfolio. It also reports the commercialization of Flexilev® across Nordic markets and continued expansion of the consumer-health portfolio. Sustainability disclosures focus on SDGs 3, 8, 12 and 13, supply-chain risk assessment, environmental initiatives, and a 40-person workforce.

Document

Report type: Annual Report with Sustainability Disclosures
Class: Embedded
Scope: Full report
Fiscal year: 2025
Period: 1 January 2025 – 31 December 2025
Publication date: 24 March 2026
Language: English
Pages
File size

Reporting standards, commitments and assurance details are available with a free account.

Materiality

Assessment
Basis

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services